Novel Markers for Detection of Complications Resulting from in Utero Encounters
Described herein are biomarkers, such as protein biomarkers, which are diagnostic of and predictive for complications that result from an in utero encounter, such as an infection by the fetus, that can lead to premature birth (PTB). The biomarkers can be used to identify fetuses and newborns at risk for complications of PTB, such as (Early Onset Neonatal Sepsis) EONS, intra-ventricular hemorrhage (IVH) and other poor outcomes.
BUHIMSCHI CATALIN S [US]; BUHIMSCHI IRINA [US]; BHANDARI VINEET [US]
Type of Offer:
« More Biotech Patents